313 related articles for article (PubMed ID: 24897928)
21. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
[TBL] [Abstract][Full Text] [Related]
22. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
Assefa A; Gelaw B; Getnet G; Yitayew G
BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
[TBL] [Abstract][Full Text] [Related]
23. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
[TBL] [Abstract][Full Text] [Related]
24. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
[TBL] [Abstract][Full Text] [Related]
25. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
[TBL] [Abstract][Full Text] [Related]
28. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment.
Sinha S; Shekhar RC; Singh G; Shah N; Ahmad H; Kumar N; Sharma SK; Samantaray JC; Ranjan S; Ekka M; Sreenivas V; Mitsuyasu RT
BMC Infect Dis; 2012 Jul; 12():168. PubMed ID: 22846195
[TBL] [Abstract][Full Text] [Related]
29. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
[TBL] [Abstract][Full Text] [Related]
30. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
31. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
32. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.
Kouanda S; Meda IB; Nikiema L; Tiendrebeogo S; Doulougou B; Kaboré I; Sanou MJ; Greenwell F; Soudré R; Sondo B
AIDS Care; 2012; 24(4):478-90. PubMed ID: 22148973
[TBL] [Abstract][Full Text] [Related]
33. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
[TBL] [Abstract][Full Text] [Related]
34. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
[TBL] [Abstract][Full Text] [Related]
35. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
36. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.
Velasco M; Castilla V; Sanz J; Gaspar G; Condes E; Barros C; Cervero M; Torres R; Guijarro C;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):148-52. PubMed ID: 19131895
[TBL] [Abstract][Full Text] [Related]
37. [Factors associated to survival in patients with HIV-TB in the Department of Infectious Diseases of the Arzobispo Loayza National Hospital, Perú, since 2004 to 2012].
Gamboa-Acuña B; Guillén-Zambrano R; Lizzetti-Mendoza G; Soto A; Lucchetti-Rodríguez A
Rev Chilena Infectol; 2018; 35(1):41-48. PubMed ID: 29652971
[TBL] [Abstract][Full Text] [Related]
38. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.
Dembélé M; Saleri N; Carvalho AC; Saouadogo T; Hien AD; Zabsonre I; Koala ST; Simporé J; Matteelli A
Int J Tuberc Lung Dis; 2010 Mar; 14(3):318-23. PubMed ID: 20132623
[TBL] [Abstract][Full Text] [Related]
39. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
Siika AM; Yiannoutsos CT; Wools-Kaloustian KK; Musick BS; Mwangi AW; Diero LO; Kimaiyo SN; Tierney WM; Carter JE
PLoS One; 2013; 8(1):e53022. PubMed ID: 23301015
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management.
Yang H; Liu Q; Wu Y; He K; Zeng Q; Liu M
BMC Infect Dis; 2024 Jan; 24(1):5. PubMed ID: 38166781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
